Open Government Canada
Notice: Prescription Drug List (PDL): Fluticasone propionate
Published by Health Canada | Santé Canada
About this dataset
The purpose of this Notice of Amendment is to notify that Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt certain uses of Fluticasone propionate.